Immune, inflammatory and prothrombotic parameters in COVID-19 patients treated with an anti EGFR antibody

Article

Abstract: SARS-CoV-2 infection causes a range of clinical presentations and induces changes in both innate and

Palabras claves:

covid-19, eGFR, inflammation, nimotuzumab, SARS-COV-2, T cells

Autores:

Añe-Kouri A.L., Armada J.J., González Y.Z., Gregorich E.M.L., Londres H.D., Luaces P.L.o., Martínez A.H., Medel L., Mena J., Ramos M., Saavedra Hernández D., Sánchez Y.H., Tania Crombet, Troche M.

Fuentes:

scopus